Vitamin E: Potential to reduce common complications associated with venous access devices in cancer patients

Cynthia Chernecky; Denise Macklin; Katherine Nugent; Jennifer Waller

Vitamin E: Potential to reduce common complications associated with venous access devices in cancer patients

Cynthia Chernecky, Denise Macklin, Katherine Nugent, Jennifer Waller

Research output: Contribution to journal › Article › peer-review

Abstract

Vitamin E is known to have antiplatelet, fibrinolytic, and endotoxin properties. Focus-group discussion with cancer patients who had a venous access device (VAD) revealed that 14 percent felt taking vitamin E (400-800 IU/d orally) eliminated the problems of occlusion and inability to withdraw blood from their current VADs. This information is significant in that two of the patients had these problems with their previous VADs but not with their current VADs, although they were the same type of device. These findings suggest that use of vitamin E to reduce occlusion and inability to withdraw blood in cancer patients with VADs should be investigated further.

Original language	English (US)
Pages (from-to)	38-40
Number of pages	3
Journal	Journal of Cancer Integrative Medicine
Volume	3
Issue number	1
State	Published - Dec 1 2005

Keywords

Complementary medicine
Neoplasm
Nursing
Venous access device
Vitamin E

ASJC Scopus subject areas

Oncology
Complementary and alternative medicine
Pharmacology (medical)

Cite this

@article{e9821672d51b435884260d51cc3c7253,

title = "Vitamin E: Potential to reduce common complications associated with venous access devices in cancer patients",

abstract = "Vitamin E is known to have antiplatelet, fibrinolytic, and endotoxin properties. Focus-group discussion with cancer patients who had a venous access device (VAD) revealed that 14 percent felt taking vitamin E (400-800 IU/d orally) eliminated the problems of occlusion and inability to withdraw blood from their current VADs. This information is significant in that two of the patients had these problems with their previous VADs but not with their current VADs, although they were the same type of device. These findings suggest that use of vitamin E to reduce occlusion and inability to withdraw blood in cancer patients with VADs should be investigated further.",

keywords = "Complementary medicine, Neoplasm, Nursing, Venous access device, Vitamin E",

author = "Cynthia Chernecky and Denise Macklin and Katherine Nugent and Jennifer Waller",

year = "2005",

month = dec,

day = "1",

language = "English (US)",

volume = "3",

pages = "38--40",

journal = "Journal of Cancer Integrative Medicine",

issn = "1544-6301",

publisher = "Prime National Publishing Corp.",

number = "1",

}

TY - JOUR

T1 - Vitamin E

T2 - Potential to reduce common complications associated with venous access devices in cancer patients

AU - Chernecky, Cynthia

AU - Macklin, Denise

AU - Nugent, Katherine

AU - Waller, Jennifer

PY - 2005/12/1

Y1 - 2005/12/1

N2 - Vitamin E is known to have antiplatelet, fibrinolytic, and endotoxin properties. Focus-group discussion with cancer patients who had a venous access device (VAD) revealed that 14 percent felt taking vitamin E (400-800 IU/d orally) eliminated the problems of occlusion and inability to withdraw blood from their current VADs. This information is significant in that two of the patients had these problems with their previous VADs but not with their current VADs, although they were the same type of device. These findings suggest that use of vitamin E to reduce occlusion and inability to withdraw blood in cancer patients with VADs should be investigated further.

AB - Vitamin E is known to have antiplatelet, fibrinolytic, and endotoxin properties. Focus-group discussion with cancer patients who had a venous access device (VAD) revealed that 14 percent felt taking vitamin E (400-800 IU/d orally) eliminated the problems of occlusion and inability to withdraw blood from their current VADs. This information is significant in that two of the patients had these problems with their previous VADs but not with their current VADs, although they were the same type of device. These findings suggest that use of vitamin E to reduce occlusion and inability to withdraw blood in cancer patients with VADs should be investigated further.

KW - Complementary medicine

KW - Neoplasm

KW - Nursing

KW - Venous access device

KW - Vitamin E

UR - http://www.scopus.com/inward/record.url?scp=33644693031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644693031&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33644693031

SN - 1544-6301

VL - 3

SP - 38

EP - 40

JO - Journal of Cancer Integrative Medicine

JF - Journal of Cancer Integrative Medicine

IS - 1

ER -

Vitamin E: Potential to reduce common complications associated with venous access devices in cancer patients

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this